Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Matrix Metalloproteinase 8: Could it Benefit the CAR-T Cell Therapy of Solid Tumors?- a- Commentary on Therapeutic Potential.

Literature DB >> 29589335

Matrix Metalloproteinase 8: Could it Benefit the CAR-T Cell Therapy of Solid Tumors?- a- Commentary on Therapeutic Potential.

Alireza Mardomi^1,2, Saeid Abediankenari^3,4.

Abstract

Entities: Disease Gene

Year: 2018 PMID： 29589335 PMCID： PMC6008262 DOI： 10.1007/s12307-018-0208-2

Source DB: PubMed Journal: Cancer Microenviron ISSN： 1875-2284

× No keyword cloud information.

35 in total

1. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors: Odete Mendes; Hun-Taek Kim; George Stoica
Journal: Clin Exp Metastasis Date: 2005 Impact factor: 5.150

Review 2. Matrix metalloproteinases and the regulation of tissue remodelling.

Authors: Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal: Nat Rev Mol Cell Biol Date: 2007-03 Impact factor: 94.444

3. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Authors: Daniel W Lee; James N Kochenderfer; Maryalice Stetler-Stevenson; Yongzhi K Cui; Cindy Delbrook; Steven A Feldman; Terry J Fry; Rimas Orentas; Marianna Sabatino; Nirali N Shah; Seth M Steinberg; Dave Stroncek; Nick Tschernia; Constance Yuan; Hua Zhang; Ling Zhang; Steven A Rosenberg; Alan S Wayne; Crystal L Mackall
Journal: Lancet Date: 2014-10-13 Impact factor: 79.321

4. Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors: Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal: N Engl J Med Date: 2014-10-16 Impact factor: 91.245

Review 5. Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors: Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal: Cancer Cell Date: 2015-04-06 Impact factor: 31.743

6. Fine-tuning Tumor Immunity with Integrin Trans-regulation.

Authors: Joseph M Cantor; David M Rose; Marina Slepak; Mark H Ginsberg
Journal: Cancer Immunol Res Date: 2015-01-19 Impact factor: 11.151

7. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.

Authors: Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens
Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956

8. Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors: Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal: Nat Med Date: 2016-01 Impact factor: 53.440

9. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.

Authors: Julie Decock; Wouter Hendrickx; Sally Thirkettle; Ana Gutiérrez-Fernández; Stephen D Robinson; Dylan R Edwards
Journal: Breast Cancer Res Date: 2015-03-14 Impact factor: 6.466